Question 21

Patient package insert (PPI) is required for oral contraceptives.

Oral contraceptives are specifically required to have a Patient Package Insert (PPI) to provide essential information about their use, risks, and benefits to patients.

A) Androgens

Androgens do not require a Patient Package Insert (PPI). While information about androgens is important, it is not mandated that they come with a PPI, as this requirement is specifically for certain medications that have significant risks or require specific patient education.

B) Oral contraceptives

Oral contraceptives are required to include a Patient Package Insert (PPI) as they carry important safety information regarding potential side effects, risks of thrombosis, and guidance on proper usage, which helps ensure informed patient consent and awareness.

C) Corticosteroids

Corticosteroids are not required to have a Patient Package Insert (PPI). While corticosteroids have important usage guidelines and potential side effects, they do not carry the same level of risk that necessitates a PPI for patient education, unlike oral contraceptives.

D) Oral chemotherapy

Oral chemotherapy agents do not require a Patient Package Insert (PPI). Although these medications come with serious side effects and require patient education, the specific regulatory requirement for a PPI is not applicable in the same way it is for oral contraceptives.

Conclusion

The requirement for a Patient Package Insert (PPI) is specifically tied to the need for comprehensive patient education regarding the risks and benefits associated with oral contraceptives. Other options such as androgens, corticosteroids, and oral chemotherapy may involve significant considerations but do not necessitate a PPI, making option B the definitive correct answer.